Tomoyo Hamana

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Predictors of target lesion revascularisation after drug-eluting stent implantation for calcified nodules: an optical coherence tomography study

Tomoyo Hamana, Hiroyuki Kawamori, Takayoshi Toba et al. · EuroIntervention · 2023 · 27 citations · Full text

Medicine, Radiology, Biomedical Imaging +10

Medial arterial calcification in ageing and disease: current evidence and knowledge gaps

Peter Lanzer, Leon J. Schurgers, Aleksandra Twarda‐Clapa et al. · European Heart Journal · 2025 · 19 citations · Full text

Medicine, Cardiology, Geriatric Medicine +14

Enhanced Plaque Stabilization Effects of Alirocumab　― Insights From Artificial Intelligence-Aided Optical Coherence Tomography Analysis of the Alirocumab for Thin-Cap Fibroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography (ALTAIR) Study ―

Tetsuya Yamamoto, Yoichiro Sugizaki, Hiroyuki Kawamori et al. · Circulation Journal · 2024 · 17 citations · Full text

Medicine, Cardiology, Pharmacology +17

Aetiology of Chronic Heart Failure in Patients from a Super-Aged Society: The KUNIUMI Registry Chronic Cohort

Wataru Fujimoto, Ryuji Toh, Misa Takegami et al. · ESC Heart Failure · 2022 · 15 citations · Full text

Medicine, Cardiology, Geriatric Medicine +14